I'm LongbridgeAI, I can summarize articles.CoreWeave's (CRWV) Q3 results delivered exactly what the market needed to hear to start changing its sentiment toward the company. Before earnings, the stock had fallen nearly 65% from its May peak, dropping from $138 to less than $49. Rising debt and fears of an artificial intelligence (AI) investment bubble were among the biggest concerns.
However, Q3 painted a very different picture. The graphics processing unit (GPU) cloud provider is still struggling to keep up with demand, rather than finding customers for its growing capacity. Despite its massive debt load, CoreWeave's financing hasn't dried up as many bears feared.
In my view, these results weaken two of the strongest bearish arguments against CoreWeave. Even after the stock's positive reaction to earnings, I still see room for a much stronger recovery, supporting my Buy rating.
AI Demand Still Far Exceeds Available Capacity
CoreWeave's recent Q3 results reinforced the idea that demand for AI computing still far exceeds available capacity. In other words, the company's main bottleneck remains on the supply side.
The company made it clear that qualified demand for AI computing is ten times its available capacity through the end of 2027. For 2028, demand also exceeds projected capacity several times over. While qualified demand reflects pipeline interest rather than binding commitments, the surge in CoreWeave's revenue backlog — which rose from roughly $104 billion in Q2 to $132.5 billion — shows that interest is converting into concrete orders.
Meanwhile, quarterly revenue grew 168% year-over-year to $3.66 billion. This shows that CoreWeave has been able to turn orders into revenue while securing new commitments. That certainly doesn't look like a market already saturated with excess supply.
Pricing Power Pushes Back Against Fears of Oversupply
Perhaps the most compelling sign of scarcity lies in pricing. CoreWeave said it raised GPU prices by about 25% in July and another 10% during the quarter, with further increases expected in Q4. Even older-generation Nvidia (NVDA) GPUs, such as Ampere and Hopper, saw price increases of 30% to 50% from the previous quarter. This challenges the idea that these GPUs quickly lose their economic value when newer chips arrive.
The company has more than 130,000 GPUs with contracts expiring in 2027. It estimates that renewing them at current prices could generate nearly $4 billion in additional annualized revenue, without significant new hardware investments. While this is a projection, and not guaranteed revenue, it shows how much more CoreWeave could earn from its existing GPU fleet.
Financing Remains Available Despite Heavy Debt
Debt is probably the strongest bearish argument against CoreWeave today. Its total debt reached $46.9 billion in Q3, while net interest expenses totaled $846 million. Still, the results showed that access to financing remains available, easing some of the biggest fears behind CRWV stock's sharp decline this year.
The company has approximately $5 billion in committed but unused credit lines. It also expects another $9 billion in customer prepayments and deposits over the next three months. More importantly, loans backed by contracts continue to cover 70% to 100% of the related capex, so that's certainly good to hear. Meanwhile, the average cost of debt fell by 2.5 percentage points over the past year to 7.9%.
According to management, cash flows from existing contracts should be enough to repay the debt and cover interest payments. That's an ambitious projection, but one that helps ease fears of an imminent financing crisis. That's precisely what investors needed to hear, and what CoreWeave delivered in Q3.
Capex Keeps Accelerating, but Risks Remain
Capex shows none of the typical slowdown of a losing investment cycle. CoreWeave raised the lower end of its 2026 capex guidance from $35 billion to $37 billion, keeping the upper end at $39 billion. For shareholders, though, what matters is how much growth is already priced in.
With CRWV trading at $48.73 before earnings, projected 2027 revenue of $27.05 billion offers a basis for valuation. Applying a 4.5x EV/revenue multiple, which I don't consider too aggressive compared to the current "under stress" 3.8x, gives an enterprise value of roughly $119 billion. Subtracting $74.3 billion in projected net debt, broadly in line with market estimates and consistent with heavy capex, leaves an equity value of $44.5 billion. Using 551.5 million shares, that implies an $81 price target.
Of course, this base case assumes steady execution and limited dilution. Both remain real risks, although Q3 helped ease some concerns.
Is CRWV a Buy, According to Wall Street Analysts?
Wall Street's CRWV forecast remains fairly bullish following Q3, with an overall Moderate Buy consensus. Of the 29 analyst ratings, 20 are Buy, six are Hold, and three are Sell. Meanwhile, the average CoreWeave price target stands at $106.62, implying a very strong upside potential of 75.44% from current levels.
A Re-Rating Could Be on the Horizon
I believe CoreWeave's Q3 results helped ease two major concerns that have weighed on the stock: whether demand for AI computing still far exceeds supply, and whether funding could become a bigger problem. The latest quarter reinforced both points. I think that opens the door to a valuation multiple re-rating, which would be especially welcome after the stock's steep sell-off.
That being the case, I see this as a good opportunity to accumulate CRWV shares. Even after the market's positive reaction to earnings, I believe there's still plenty of room for upside, supporting my Buy rating.